Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Julia Rotow
Person

Julia Rotow

Tracked across 1 events · 6 articles · First seen May 21, 2026 · Last active May 21, 2026

Sentiment
50
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 50
Business
Black Diamond Therapeutics' Silevertinib Phase 2 Success
Impact: Julia Rotow, Clinical Director at the Dana–Farber Cancer Institute, will present the positive Silevertinib data at the ASCO Annual Meeting, lending credibility to the findings.
May 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Julia Rotow live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.